AXSM vs NVR · rev $409.6M vs P/E 15, rev $4.21B
Axsome Therapeutics Inc (AXSM) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
AXSM currently screens at market cap $11.96B. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the AXSM and NVR stock pages for the full models.
Not investment advice.